Overview

Modulation of Immunity-related Gene Expression Under the Chinese Herbal Formula SS-1 Treatment for Sjögren's Syndrome

Status:
Unknown status

Trial end date:
2017-04-01

Target enrollment:

Participant gender:

Summary

To evaluate the modulation of immunity-related gene expression for the Sjögren's syndrome under Chinese herbal medicine (SS-1) treatment.

Phase:

Phase 2

Details

Lead Sponsor:

China Medical University Hospital

Collaborators:

Chang Gung Memorial Hospital
China Medical University, China
National Research Program for Biopharmaceuticals (NRPB)
National Research Program for Biopharmaceuticals, Taiwan